Safety of low-dose prostaglandin E2 induction in grandmultiparous women with previous cesarean delivery

J Matern Fetal Neonatal Med. 2014 Mar;27(5):445-8. doi: 10.3109/14767058.2013.818651. Epub 2013 Jul 26.

Abstract

Objective: To determine the safety and efficacy of labor induction with low-dose vaginal prostaglandin E2 (PGE2) in grandmultiparous women with a previous cesarean delivery.

Methods: We conducted a retrospective cohort study of 219 grandmultiparous women with a previous cesarean delivery (study group) who underwent induction of labor with low dose PGE2. These patients were compared to 1376 grandmultiparous women without a previous cesarean section (control group) who underwent induction of labor with low dose PGE2. The primary outcome was uterine rupture and secondary outcomes included mode of delivery, post-partum hemorrhage (PPH) and a low 5-min Apgar score (≤7).

Results: One patient in the study group as well as one patient in the control group were diagnosed with uterine rupture (0.4% versus 0.07%). In the study group, vaginal delivery was achieved in 204 (93.16%) patients, whereas 15 (6.84%) patients had emergent cesarean delivery. Five minutes Apgar score ≤7 was recorded in two cases (0.9%) in the study group. Patients in the study group had a significantly higher rate of cesarean delivery (6.84%, versus 3.4%, respectively, p < 0.001) as well as operative vaginal delivery (4.56% versus 2% respectively, p < 0.05) compared to the control group. There were no significant differences between the groups regarding the rate of PPH (0.91% versus 0.90%, p = 0.2) or 5-min Apgar score ≤7 (0.91% versus 0.22%, p = 0.28).

Conclusions: Low dose PGE2 is a relative safe method for induction of labor in grandmultiparous women with a previous cesarean section.

Publication types

  • Evaluation Study

MeSH terms

  • Administration, Intravaginal
  • Adult
  • Case-Control Studies
  • Dinoprostone / administration & dosage*
  • Dinoprostone / adverse effects*
  • Dose-Response Relationship, Drug
  • Female
  • Humans
  • Labor, Induced / adverse effects
  • Labor, Induced / methods*
  • Labor, Induced / statistics & numerical data
  • Middle Aged
  • Oxytocics / administration & dosage*
  • Oxytocics / adverse effects*
  • Parity* / drug effects
  • Pregnancy
  • Pregnancy Outcome / epidemiology
  • Retrospective Studies
  • Treatment Outcome
  • Uterine Rupture / epidemiology
  • Vaginal Birth after Cesarean* / adverse effects
  • Vaginal Birth after Cesarean* / methods
  • Vaginal Birth after Cesarean* / statistics & numerical data

Substances

  • Oxytocics
  • Dinoprostone